“Acute cholecystitis”的搜索结果，显示 101-110 项，共有 9269 项

1. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

2. 血液科- 临床试验- 妙佑医疗国际

   ... acute setting and infections and financial burden in the long-term setting, a longitudinal study that assesses these issues in a quantitative and ...

3. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

4. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

5. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

6. 神经科- 临床试验- 妙佑医疗国际

   VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore ...

7. 临床试验- 妙佑医疗国际儿童中心

   ... severe COVID-19 based on the TCR repertoires. This may be accomplished by testing and analyzing results between two cohorts: patients presenting acutely to ...

8. 肺科- 临床试验- 妙佑医疗国际

   The primary purpose of this study is to examine 1-year survival and rate of secondary infections in COVID-19 patients with and without acute kidney injury (AKI) ...

9. 阑尾炎 - 医生与科室- 妙佑医疗国际

   Roderick W. Davis, M.D.. Acute Care Surgeon, Critical Care Surgeon, General Surgeon, Trauma Surgeon. Rochester, MN ...

10. 临床试验- 妙佑医疗国际儿童中心

    ... severe COVID-19 based on the TCR repertoires. This may be accomplished by testing and analyzing results between two cohorts: patients presenting acutely to ...